At present, it is known that Cks1 overexpression can occur due to gene amplification in breast cancer [12] and myeloma [28, 29], and CKS1 is a transcriptional target of c-Myc, B-RAF, and cyclin D1 [30, 31]. This evidence concerns the gene CCND1 and plasma cell myeloma.